Malaria drug touted by Trump fails to prevent COVID-19 in high profile study

By Michael Erman (Reuters) - The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated clinical trial released on Wednesday. The new trial found no serious side effects or heart problems from use of hydroxychloroquine. Vocal support from Trump kicked off a heated debate and raised expectations for the decades-old drug that could be a cheap and widely available tool in fighting the pandemic that has infected more than 6.4 million people and killed over 382,000 worldwide In the first major study...